|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.72 USD | -2.75% |
|
-8.01% | -20.05% |
| 07:41am | Morgan Stanley Lowers Price Target on Veracyte to $37 From $48, Keeps Underweight Rating | MT |
| Mar. 04 | Veracyte Insider Sold Shares Worth $485,429, According to a Recent SEC Filing | MT |
| Capitalization | 2.76B 2.38B 2.14B 2.06B 3.75B 253B 3.93B 25.35B 10.16B 121B 10.34B 10.12B 434B | P/E ratio 2026 * |
38x | P/E ratio 2027 * | 31.9x |
|---|---|---|---|---|---|
| Enterprise value | 2.23B 1.92B 1.74B 1.67B 3.04B 205B 3.18B 20.54B 8.23B 98.39B 8.38B 8.2B 352B | EV / Sales 2026 * |
3.87x | EV / Sales 2027 * | 3.22x |
| Free-Float |
99.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Veracyte, Inc.
| 1 day | -2.77% | ||
| 1 week | -8.01% | ||
| Current month | -8.01% | ||
| 1 month | -6.99% | ||
| 3 months | -24.12% | ||
| 6 months | +3.70% | ||
| Current year | -20.05% |
| 1 week | 33.11 |  | 36.82 |
| 1 month | 33.11 | | 39.89 |
| Current year | 33.11 | | 46.76 |
| 1 year | 22.61 | | 50.71 |
| 3 years | 18.61 | | 50.71 |
| 5 years | 14.85 | | 59.84 |
| 10 years | 4.21 | | 86.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 56 | 2021-05-31 |
Rebecca Chambers
DFI | Director of Finance/CFO | 48 | 2021-07-18 |
Phillip Febbo
CTO | Chief Tech/Sci/R&D Officer | 59 | 2023-10-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Jones
BRD | Director/Board Member | 69 | 2008-01-31 |
Karin Eastham
BRD | Director/Board Member | 76 | 2012-11-30 |
Robert Epstein
CHM | Chairman | 71 | 2023-04-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.75% | -8.01% | +3.54% | +41.85% | 2.76B | |
| +0.10% | +0.07% | +121.81% | +54.33% | 19.72B | |
| +1.51% | -6.26% | -28.85% | -22.15% | 2.47B | |
| -6.21% | -6.80% | +92.15% | +76.48% | 2.45B | |
| +9.93% | +30.31% | +34.13% | -27.52% | 1.89B | |
| +6.06% | -6.76% | +673.49% | - | 1.2B | |
| -4.48% | -5.12% | -5.82% | +67.14% | 960M | |
| +0.44% | -4.19% | -18.72% | -7.22% | 746M | |
| -0.63% | -11.61% | -1.46% | -2.88% | 737M | |
| -3.67% | 0.00% | +33.33% | -77.43% | 539M | |
| Average | +0.05% | -1.01% | +90.36% | +11.40% | 3.35B | |
| Weighted average by Cap. | +0.09% | -0.58% | +102.64% | +39.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 577M 497M 449M 431M 785M 53B 822M 5.31B 2.13B 25.42B 2.16B 2.12B 90.91B | 648M 559M 504M 484M 882M 59.54B 923M 5.96B 2.39B 28.55B 2.43B 2.38B 102B |
| Net income | 75.29M 64.92M 58.6M 56.23M 103M 6.92B 107M 693M 278M 3.32B 283M 277M 11.87B | 92.28M 79.57M 71.83M 68.92M 126M 8.48B 132M 849M 340M 4.07B 346M 339M 14.55B |
| Net Debt | -523M -451M -407M -391M -712M -48.08B -746M -4.81B -1.93B -23.06B -1.96B -1.92B -82.46B | -666M -574M -519M -498M -907M -61.23B -950M -6.13B -2.46B -29.36B -2.5B -2.45B -105B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-06 | 33.66 $ | -2.94% | 442,028 |
| 26-03-05 | 34.68 $ | -4.38% | 978,381 |
| 26-03-04 | 36.27 $ | +3.39% | 931,601 |
| 26-03-03 | 35.08 $ | -2.58% | 984,736 |
| 26-03-02 | 36.01 $ | -1.59% | 1,223,603 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VCYT Stock
Select your edition
All financial news and data tailored to specific country editions
